Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

General Research Article

A HPLC-DAD-MS/MS Method for Simultaneous Determination of Six Active Ingredients of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection in Rat Plasma and its Application to Pharmacokinetic Studies

Author(s): Jianyang Pan, Luquan Zhang, Difeifei Xiong, Bailing Li and Haibin Qu*

Volume 22, Issue 1, 2021

Published on: 19 August, 2020

Page: [60 - 69] Pages: 10

DOI: 10.2174/1389200221999200819143230

Price: $65

Abstract

Aims: This is a pharmacokinetic study of Salviae miltiorrhizae and ligustrazine hydrochloride injection. The study aimed to evaluate the mechanism of action, safety and rational clinical use of Salviae miltiorrhizae and ligustrazine hydrochloride injection.

Background: Salviae miltiorrhizae and ligustrazine hydrochloride injection is a compound preparation consisted of Salvia miltiorrhiza extract and ligustrazine hydrochloride for the treatment of cardiovascular and cerebrovascular diseases in China.

Objective: The study aimed to develop a rapid and sensitive high-performance liquid chromatography-diode array detector-tandem mass spectrometry (HPLC-DAD-MS/MS) method for simultaneous determination of six major active ingredients of Salviae miltiorrhizae and ligustrazine hydrochloride injection, namely danshensu, protocatechuic aldehyde, rosmarinic acid, lithospermic acid, salvianolic acid A, and ligustrazine hydrochloride, in rat plasma.

Methods: Plasma samples were precipitated with methanol, which was spiked with ascorbic acid and the supernatant was separated on a Waters Cortecs C18 column, by using a gradient mobile phase system of acetonitrile-water containing 0.05% formic acid (v/v). For internal standards, puerarin was selected for the five salvianolic acids, while isofraxidin was used for ligustrazine hydrochloride. Besides, electrospray ionization in negative mode and multiplereaction monitoring were used to identify and quantify the five salvianolic acids, whereas ligustrazine hydrochloride was quantified at 310 nm using the diode array detector.

Results: Noticeably, all calibration curves showed good linearity (R2>0.99) over the concentration range, with a lower limit of quantification between 0.00411 and 0.0369 μg/mL for salvianolic acids, and 1.74 μg/mL for ligustrazine hydrochloride. Next, the precision of the developed method was evaluated by intra- and inter-day assays, and the percentage of relative standard deviation was within 10%. Although the extraction efficiency of some salvianolic acids was not very satisfactory, the sensitivity of the analytical method met the analysis requirements of rat plasma samples. Moreover, the validated method was successfully applied to a pharmacokinetic study of Salviae miltiorrhizae and ligustrazine hydrochloride injection in the rat model.

Conclusion: Linear pharmacokinetic characteristics were observed for the six active ingredients after intravenous infusion administration in rats within the dose range examined here. In summary, our study proposed a HPLC-DADMS/ MS method with the simultaneous determination of multiple ingredients, and demonstrated its applicability in pharmacokinetic studies.

Keywords: HPLC-DAD-MS/MS, pharmacokinetic, Salviae miltiorrhizae and ligustrazine hydrochloride injection, danshensu, ligustrazine hydrochloride.

Graphical Abstract
[1]
Fu, L.L.; Zhang, B.J.; Qiu, X.M. Efficacy of combined atorvastatin calcium, Salviae miltiorrhizae and ligustrazine hydrochloride injection in cerebral infarction patients. Trop. J. Pharm. Res., 2018, 17(9), 1875-1879.
[http://dx.doi.org/10.4314/tjpr.v17i9.28]
[2]
Xie, B.C.; Chen, S.C.; Wang, Q.H.; Zhou, C.H.; Wu, J.H.; Xu, D.H. Systematic review on efficacy and safety of danshen chuanxiongqin injection in treatment of acute cerebral infarction. Zhongguo Zhongyao Zazhi, 2018, 43(17), 3573-3581.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20180611.015] [PMID: 30347928]
[3]
Zhang, D.L.; Ying, L.; Jiang, F.; Guo, F.; Hao, W.H. Effect of danshen ligustrazine injection combined with isosorbide mononitrate on blood lipid level and efficacy in patients with coronary heart disease unstable angina pectoris. Zhonghua Zhongyiyao Xuekan, 2019, 37(6), 1451-1454.
[4]
Zhuang, W.B. Clinical observation of Salvia miltiorrhiza and ligustrazine injection in the treatment of angina pectoris of senile coronary heart disease. J. Cardiovasc. Surg. (Torino), 2019, 8(2), 73. [Electronic Edition].
[5]
Huang, W.; Yang, Y.; Zeng, Z.; Su, M.; Gao, Q.; Zhu, B. Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury. Mol. Med. Rep., 2016, 14(5), 4537-4544.
[http://dx.doi.org/10.3892/mmr.2016.5822] [PMID: 27748867]
[6]
Gao, Y.; Wang, G.Q.; Wang, J.; Zhang, M.X.; Xie, Y.M.; Liu, H.; Jiang, J.J. Expert consensus statement on danshen chuanxiongqin injection in clinical practice. Zhongguo Zhongyao Zazhi, 2019, 44(14), 2937-2942.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20190509.503] [PMID: 31602836]
[7]
Chen, L.B.; He, R.; Li, H.; Li, B.L.; Zhang, L.Q.; Pan, J.Y.; Qu, H.B. Fingerprint and multi-component quantitative analysis of Salvia miltiorrhiza extract intermediate from xutong injection. Chinese J. Modern Appl. Pharm. accepted,,
[8]
Li, Z.M.; Xu, S.W.; Liu, P.Q. Salvia miltiorrhiza Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol. Sin., 2018, 39(5), 802-824.
[http://dx.doi.org/10.1038/aps.2017.193] [PMID: 29698387]
[9]
Lin, T.H.; Hsieh, C.L. Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin. Med., 2010, 5, 22-27.
[http://dx.doi.org/10.1186/1749-8546-5-22] [PMID: 20565944]
[10]
Jiang, R.W.; Lau, K.M.; Hon, P.M.; Mak, T.C.; Woo, K.S.; Fung, K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem., 2005, 12(2), 237-246.
[http://dx.doi.org/10.2174/0929867053363397] [PMID: 15638738]
[11]
MEIm X.D.; Cao, Y.F.; Che, Y.Y.; Li, J.; Shang, Z.P.; Zhao, W.J.; Qiao, Y.J.; Zhang, J.Y. Danshen: a phytochemical and pharmacological overview. Chin. J. Nat. Med., 2019, 17(1), 59-80.
[http://dx.doi.org/10.1016/s1875-5364(19)30010-x] [PMID: 30704625]
[12]
Chen, Y.; Zhang, N.; Ma, J.; Zhu, Y.; Wang, M.; Wang, X.; Zhang, P. A platelet/CMC coupled with offline UPLC-QTOF-MS/MS for screening antiplatelet activity components from aqueous extract of Danshen. J. Pharm. Biomed. Anal., 2016, 117, 178-183.
[http://dx.doi.org/10.1016/j.jpba.2015.06.009] [PMID: 26355772]
[13]
Huang, D.D.; Wei, X.H.; Mu, H.N.; Pan, C.S.; Li, Q.; Hu, B.H.; Chang, X.; Yan, L.; Fan, J.Y.; Liu, Y.Y.; Luo, J.Y.; Han, J.Y. Total salvianolic acid injection prevents ischemia/reperfusion-induced myocardial injury via antioxidant mechanism involving mitochondrial respiratory chain through the upregulation of sirtuin1 and sirtuin3. Shock, 2019, 51(6), 745-756.
[http://dx.doi.org/10.1097/SHK.0000000000001185] [PMID: 29863652]
[14]
Fan, G.; Yu, J.; Asare, P.F.; Wang, L.; Zhang, H.; Zhang, B.; Zhu, Y.; Gao, X. Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling. J. Cell. Mol. Med., 2016, 20(10), 1908-1919.
[http://dx.doi.org/10.1111/jcmm.12883] [PMID: 27385290]
[15]
Wei, G.; Guan, Y.; Yin, Y.; Duan, J.; Zhou, D.; Zhu, Y.; Quan, W.; Xi, M.; Wen, A. Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation, 2013, 36(3), 592-602.
[http://dx.doi.org/10.1007/s10753-012-9581-z] [PMID: 23269534]
[16]
Chien, M.Y.; Chuang, C.H.; Chern, C.M.; Liou, K.T.; Liu, D.Z.; Hou, Y.C.; Shen, Y.C. Salvianolic acid A alleviates ischemic brain injury through the inhibition of inflammation and apoptosis and the promotion of neurogenesis in mice. Free Radic. Biol. Med., 2016, 99, 508-519.
[http://dx.doi.org/10.1016/j.freeradbiomed.2016.09.006] [PMID: 27609227]
[17]
Liu, Z.J.; Wu, Y.; Jiang, X.H.; Liu, X.J.; Wang, L.; Zhang, R.; Yang, L. Pharmacokinetic study of Tanshinol’s impact on ligustrazine hydrochloride from Salvia miltiorrhiza ligustrazine hydrochloride injection in rats. Huaxi Yaoxue Zazhi, 2017, 32(2), 182-185.
[18]
Liu, X.J.; Zhang, R.; Yang, L.; Jiang, X.H. Pharmacokinetics and tissue distribution study of ligustrazine hydrochloride in Salviae miltiorrhiza ligustrazine hydrochloride injection in mice. Chung Kuo Yao Hsueh Tsa Chih, 2014, 49(19), 1734-1739.
[19]
Wu, Y.; Wang, L.; Jiang, X.H.; Zhang, R.; Yang, L. Pharmacokinetics study of ligustrazine in Salviae miltiorrhiza ligustrazine hydrochloride injection in beagle dogs. Zhongguo Yiyuan Yaoxue Zazhi, 2014, 34(2), 98-102.
[20]
Wang, Q.; Sun, H.; Yu, L.; Ma, X.; Jiang, B.; Bi, C.; Wang, Z.; Fan, Q.; Yu, Y.; Liu, Y.; Nie, H. Pharmacokinetic behaviors of ligustrazine after single- and multiple-dose intravenous Shenxiong glucose injection in rats by high-performance liquid chromatography. Naunyn Schmiedebergs Arch. Pharmacol., 2019, 392(5), 565-572.
[http://dx.doi.org/10.1007/s00210-018-01608-9] [PMID: 30607470]
[21]
Zheng, L.; Gong, Z.; Lu, Y.; Xie, Y.; Huang, Y.; Liu, Y.; Lan, Y.; Wang, A.; Wang, Y.A. UPLC-MS/MS method for simultaneous determination of danshensu, protocatechuic aldehyde, rosmarinic acid, and ligustrazine in rat plasma, and its application to pharmacokinetic studies of Shenxiong glucose injection in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 997, 210-217.
[http://dx.doi.org/10.1016/j.jchromb.2015.06.008] [PMID: 26118621]
[22]
Li, M.; Wang, F.; Huang, Y.; Du, F.; Zhong, C.; Olaleye, O.E.; Jia, W.; Li, Y.; Xu, F.; Dong, J.; Li, J.; Lim, J.B.R.; Zhao, B.; Jia, L.; Li, L.; Li, C. Systemic exposure to and disposition of catechols derived from Salvia miltiorrhiza roots (Danshen) after intravenous dosing DanHong injection in human subjects, rats, and dogs. Drug Metab. Dispos., 2015, 43(5), 679-690.
[http://dx.doi.org/10.1124/dmd.114.061473] [PMID: 25670806]
[23]
Li, X.; Du, F.; Jia, W.; Olaleye, O.E.; Xu, F.; Wang, F.; Li, L. Simultaneous determination of eight Danshen polyphenols in rat plasma and its application to a comparative pharmacokinetic study of DanHong injection and Danshen injection. J. Sep. Sci., 2017, 40(7), 1470-1481.
[http://dx.doi.org/10.1002/jssc.201601340] [PMID: 28139096]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy